Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation
Four Indian generic companies take sub license from MPP on daclatasvir
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
Know the interactions between HIV and Hep C medicines
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
Up dated Generic Sofosbuvir availability and Price in India – 18 May 2015
Read More
Story from Ajitshwor Wangkheirakpam, Manipur, India
